Loading...
Please wait, while we are loading the content...
Similar Documents
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
| Content Provider | Scilit |
|---|---|
| Author | Desmond, Ronan Townsley, Danielle M. Dumitriu, Bogdan Olnes, Matthew J. Scheinberg, Phillip Bevans, Margaret Parikh, Ankur R. Broder, Kinneret Calvo, Katherine Wu, Colin O. Young, Neal S. Dunbar, Cynthia E. |
| Copyright Year | 2014 |
| Description | Key Points Eltrombopag promotes hematopoiesis in patients with severe aplastic anemia by stimulating stem and progenitor cells. Eltrombopag can be discontinued safely in robust responders with maintenance of hematopoiesis. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962161/pdf |
| Ending Page | 1825 |
| Page Count | 8 |
| Starting Page | 1818 |
| DOI | 10.1182/blood-2013-10-534743 |
| Journal | Blood |
| Issue Number | 12 |
| Volume Number | 123 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2014-03-20 |
| Access Restriction | Open |
| Subject Keyword | Hematology Refractory Severe Aplastic Anemia Robust Hematopoiesis Maintenance Eltrombopag Progenitor Stimulating Trilineage Journal: Blood (Vol- 121, Issue- 12) |
| Content Type | Text |
| Resource Type | Article |